Each year people living with or beyond early-onset bowel cancer, caregivers and advocates from across the country descend on Australian Parliament House for Bowel Cancer Australia’s preeminent advocacy event – Call on Canberra.

Advocates attend meetings with MPs and Senators, sharing their lived experience and raising awareness of the critical policy asks needed to improve health outcomes.

We have already made significant inroads as we know that a shared voice and purpose is a powerful tool.

Through Call on Canberra: Action on Early-onset Bowel Cancer our collective voices and lived experiences have lead the way to engage decision makers, and ultimately secure commitments to act on behalf of the over 1,700 Australians diagnosed with early-onset bowel cancer each year.

The energy is palpable, and the direct impact of our advocacy efforts speak for themselves.

  • Establishment of the Parliamentary Friends of Bowel Cancer to further the early-onset bowel cancer policy agenda within Parliament through a core group of political champions.
  • Bowel Cancer Australia has partnered with Cancer Australia through the Priority-driven Collaborative Cancer Research Scheme (PdCCRS) to support innovative and collaborative research across all aspects of early-onset bowel cancer that has the potential to improve survival and/or help build a path toward a cure.
  • National Health and Medical Research Council (NHMRC) endorsement of clinical practice guidelines lowering the age from 45 to 40 for people at average risk (i.e. without symptoms) who can request a screening test from their healthcare professional. 
  • Lowering of the National Bowel Cancer Screening Program start age from 50 to 45, with 1.6 million Australians eligible to opt-in to receive a free screening test. 
  • Bowel Cancer Australia has launched the Never2Young CPD series, a range of health care professional educational activities to help overcome perceived age bias by people under age 50 diagnosed with bowel cancer.
  • Bowel Cancer Australia in collaboration with A/Prof Daniel Buchanan, Head of the Colorectal Oncogenomics Group, Department of Clinical Pathology and Centre for Cancer Research, University of Melbourne co-hosted a national, multidisciplinary Early-Onset Bowel Cancer Research Symposium.

Collectively we continue to advocate for greater awareness (especially among GPs), rapid referrals, implementing a lower screening start age, improved pathways, as well as further research to help build a path towards a cure. 

Bowel Cancer Australia continues to put early-onset bowel cancer on the national agenda and is calling for action to improve awareness, diagnosis, treatment and care pathways for younger people.